product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-Jak2 (Tyr221) Antibody
catalog :
3774
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
reactivity :
human, mouse, rat
application :
western blot
citations: 4
Published Application/Species/Sample/DilutionReference
  • western blot; human; fig 4
Machado Neto J, de Melo Campos P, Favaro P, Lazarini M, da Silva Santos Duarte A, Lorand Metze I, et al. Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells. Oncotarget. 2015;6:29573-84 pubmed publisher
  • western blot; human
Machado Neto J, Lazarini M, Favaro P, de Melo Campos P, Scopim Ribeiro R, Franchi Junior G, et al. ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells. Biochim Biophys Acta. 2015;1853:583-93 pubmed publisher
Pulikkan J, Madera D, Xue L, Bradley P, Landrette S, Kuo Y, et al. Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling. Blood. 2012;120:868-79 pubmed publisher
Okumura M, Iwakiri T, Takagi A, Hirabara Y, Kawano Y, Arimori K. Hepatocyte growth factor suppresses the anticancer effect of irinotecan by decreasing the level of active metabolite in HepG2 cells. Biochem Pharmacol. 2011;82:1720-30 pubmed publisher
product information
SKU :
3774S
Product-Name :
Phospho-Jak2 (Tyr221) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H, M, (R)
Applications :
Western blot
Product-Category :
Immunology and Inflammation
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
125
Host :
Rabbit
Target :
Jak2 (Tyr221) phosphate
Primary-Protein :
JAK2
Alt-Names :
JAK-2,JAK2,JTK10,Janus kinase 2,Janus kinase 2 (a protein tyrosine kinase),Tyrosine-protein kinase JAK2
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.